Roger Sidhu - Sep 20, 2021 Form 4 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role: Chief Medical Officer
Signature: /s/Bella Zaslavsky, Attorney-in-Fact for Roger Sidhu
Stock symbol: ERNA
Transactions as of: Sep 20, 2021
Transactions value $: $0
Form type: 4
Date filed: 9/22/2021, 04:57 PM
Next filing: Mar 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Stock Option	Award	$0	+161K		$0.00	161K	Sep 20, 2021	Common Stock	161K	$9.96	Direct	F1
transaction	ERNA	Restricted Stock Unit	Award	$0	+80.7K		$0.00	80.7K	Sep 20, 2021	Common Stock	80.7K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on September 20, 2022, and 1/36 of the remaining shares covered thereby vesting on the twentieth day of each calendar month from October 2022 through September 20, 2025, subject to continued service through each vesting date.
F2	Each restricted stock unit represents a contingent right to receive one share of common stock.
F3	The RSU Grant vests and becomes exercisable in four equal installments on September 20 of each of 2022, 2023, 2024 and 2025, provided that it shall vest in full immediately prior to a change in control (as defined in Dr. Sidhu's Executive Employment Agreement, effective September 20, 2021), subject to continued service through each vesting date.

Remarks:

Chief Medical Officer